Skip to main navigation Skip to search Skip to main content

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

  • Mingo M H Yung
  • , Fiona A. Ross
  • , D. Grahame Hardie
  • , Thomas H Y Leung
  • , Jinbiao Zhan
  • , Hextan Y S Ngan
  • , David W. Chan (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

361 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science